Page last updated: 2024-08-21

arsenic trioxide and carfilzomib

arsenic trioxide has been researched along with carfilzomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bashash, D; Esmaeili, S; Mousavi, FS; Safaroghli-Azar, A; Yousefi, AM; Zamani-Moghaddam, N	1

Other Studies

1 other study(ies) available for arsenic trioxide and carfilzomib

Article	Year
Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment. Cancer treatment and research communications, 2021, Volume: 26 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Autophagy; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Leukemia, Promyelocytic, Acute; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors	2021

Article

Year

Suppression of proteasome induces apoptosis in APL cells and increases chemo-sensitivity to arsenic trioxide: Proposing a perception in APL treatment.

Cancer treatment and research communications, 2021, Volume: 26

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Autophagy; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; G2 Phase Cell Cycle Checkpoints; Humans; Leukemia, Promyelocytic, Acute; Oligopeptides; Proteasome Endopeptidase Complex; Proteasome Inhibitors

2021